Related references
Note: Only part of the references are listed.Tumor-Associated Macrophages: Recent Insights and Therapies
Jiawei Zhou et al.
FRONTIERS IN ONCOLOGY (2020)
Advances in Anti-Tumor Treatments Targeting the CD47/SIRPα Axis
Wenting Zhang et al.
FRONTIERS IN IMMUNOLOGY (2020)
Engineering macrophages to phagocytose cancer cells by blocking the CD47/SIRP&x251; axis
Hongcheng Yang et al.
CANCER MEDICINE (2019)
CSF1R-and SHP2-Inhibitor-Loaded Nanoparticles Enhance Cytotoxic Activity and Phagocytosis in Tumor-Associated Macrophages
Anujan Ramesh et al.
ADVANCED MATERIALS (2019)
Colon Cancer Cell Secretes EGF to Promote M2 Polarization of TAM Through EGFR/PI3K/AKT/mTOR Pathway
Guanghui Lian et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2019)
Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
Ye Li et al.
CELL STEM CELL (2018)
CAR T-cell Therapy: A New Era in Cancer Immunotherapy
Miliotou N. Androulla et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2018)
Macrophage plasticity, polarization, and function in health and disease
Abbas Shapouri-Moghaddam et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT)
A. Marabelle et al.
ANNALS OF ONCOLOGY (2018)
Immune Checkpoint Inhibition Overcomes ADCP-Induced Immunosuppression by Macrophages
Shicheng Su et al.
CELL (2018)
Intratumoral Delivery of Immunotherapy-Act Locally, Think Globally
M. Angela Aznar et al.
JOURNAL OF IMMUNOLOGY (2017)
Cancer immunotherapy targeting the CD47/SIRPα axis
Kipp Weiskopf
EUROPEAN JOURNAL OF CANCER (2017)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Pancreatic cancer cell/fibroblast co-culture induces M2 like macrophages that influence therapeutic response in a 3D model
Janina Kuen et al.
PLOS ONE (2017)
Intratumoral immunotherapy: using the tumor as the remedy
A. Marabelle et al.
ANNALS OF ONCOLOGY (2017)
SIRPA-Inhibited, Marrow-Derived Macrophages Engorge, Accumulate, and Differentiate in Antibody-Targeted Regression of Solid Tumors
Cory M. Alvey et al.
CURRENT BIOLOGY (2017)
Delivering safer immunotherapies for cancer
Lauren Milling et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy
Yoshihiro Komohara et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies
Saar Gill et al.
IMMUNOLOGICAL REVIEWS (2015)
Macrophage heterogeneity in tissues: phenotypic diversity and functions
Siamon Gordon et al.
IMMUNOLOGICAL REVIEWS (2014)
Enhanced invasion of lung adenocarcinoma cells after co-culture with THP-1-derived macrophages via the induction of EMT by IL-6
Dehai Che et al.
IMMUNOLOGY LETTERS (2014)
Macrophage cytokines: involvement in immunity and infectious diseases
Guillermo Arango Duque et al.
FRONTIERS IN IMMUNOLOGY (2014)
Signal regulatory protein is associated with tumor-polarized macrophages phenotype switch and plays a pivotal role in tumor progression
Yu-fei Pan et al.
HEPATOLOGY (2013)
Estimation of rat mammary tumor volume using caliper and ultrasonography measurements
Ana Faustino-Rocha et al.
LAB ANIMAL (2013)
Combinatorial antigen recognition with balanced signaling promotes selective tumor eradication by engineered T cells
Christopher C. Kloss et al.
NATURE BIOTECHNOLOGY (2013)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
Distinct roles for the α and β subunits in the functions of integrin αMβ2
DA Solovjov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Share Paper
